|
|
|
Table 1a
Biographical Data, Diagnosis and Therapy for Series I
|
Pat.
No.
|
Gender
|
Age
|
Diagnosis
|
Therapy
|
|
1
|
F
|
52
|
Somnipathy
Weak concentration
Dyscardia
|
3 weeks, 2 x daily for 8 mins. mornings Level 3a, eves.
Level 1
|
Soporifics
Nerve tea
|
|
2
|
M
|
64
|
Sporifics
|
|
3
|
F
|
57
|
Nerve tea
|
|
4
|
F
|
38
|
Multilocular artralgia (shoulder, hip & knee joints)
and multilocular neuralgia (BWS, LWS)
|
3 weeks, 2 x daily for 8 mins., Level 5, NSAR
|
|
5
|
F
|
48
|
|
6
|
F
|
69
|
Multilocular artralgia (shoulder, hip & knee joints)
and multilocular neuralgia (BWS, LWS)
|
3 weeks, 2 x daily for 8 mins., Level 5, NSAR
|
|
7
|
F
|
70
|
|
8
|
M
|
65
|
3 weeks, 2 x daily for 8 mins., Level 4, NSAR
|
|
9
|
M
|
82
|
|
14
|
F
|
72
|
Strong stress pain after TEP
Osteoporosis
|
3 weeks, 3 x daily for 8 mins., Level 5, NSAR
|
|
23
|
F
|
54
|
Lumbargia after BS-Op.;
Foot Lift weakness, Osteoporosis
|
4 weeks, 1 x daily for 16 mins., Level 5, NSAR
|
|
29
|
M
|
63
|
Pronounced sensation of cold in feet and lower legs (distal);
freq. nightly calf pains, morning myalgia of lower
legs and starting pain in ankle joints, vascular Doppler
test showed no significant min. vascularity
|
4 weeks, 1 x daily for 16 mins. (eves.), Level 4, no medication
|
|
30
|
M
|
68
|
|
31
|
M
|
70
|
|
32
|
M
|
70
|
|
Table 1b
Therapy Success for Series I
|
Pat.
No.
|
D
FBA (cm)
|
Medication
Reduction
|
Therapeutic
Success
|
Remarks
|
|
1
|
N/A
|
yes
(Soporific)
|
After 1 week improvement of sleep pattern, calm sleep (mostly
without interruption), significant increase in daily
performance, general psychogenic consolidation.
|
Dosage of soporifics was reduced, rarely needed (only during
extreme psychic stress), continued use of nerve tea.
|
|
2
|
|
3
|
0
|
continued use of nerve tea.
|
|
4
|
-6
|
approx. 50%
|
After 1-1.5 weeks significant improvement in pain levels
and improved mobility of spinal column and joints. Subjective
improvement in general state of health and performance
during the day.
|
Accompanying medication therapy was reduced, improved general
state of health ("feeling refreshed"). Different
falling-asleep behavior when used in the evening, but
always undisturbed night sleep.
|
|
5
|
-6
|
approx. 50%
|
|
6
|
N/A
|
approx. 30%
|
|
7
|
-2
|
approx. 30%
|
|
8
|
N/A
|
approx. 50%
|
|
9
|
N/A
|
approx. 75%
|
|
14
|
N/A
|
approx. 30%
|
After 2 weeks significant reduction of complaints, longer
walking distances.
|
Crutches used only infrequently. Termination of therapy
due to patient relocation.
|
|
23
|
N/A
|
yes
|
After 2 weeks significant improvement of Lumbargia, "Foot
lift weakness" remained unchanged.
|
NSAR only required in some cases.
|
|
29
|
N/A
|
|
Significant reduction of myalgia, ankle joint pains reduced
in the morning, significantly improved sleep quality,
cold sensation improved after approx. 3 weeks
|
|
|
30
|
N/A
|
|
31
|
N/A
|
|
32
|
N/A
|
|
Back
to Top
|
|
QRS
Research